Race in ovarian cancer treatment and survival: A systematic review with meta-analysis

Cancer Causes and Control

Volumn 20, Issue 7, 2009, Pages 1139-1150

  Terplan, Mishka ^a   Smith, Erica J ^a   Temkin, Sarah M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Healthcare disparities; Meta analysis; Ovarian neoplasms; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

AFRICAN AMERICAN; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; EMBASE; EUROPEAN AMERICAN; HEALTH CARE DISPARITY; HUMAN; LYMPH NODE DISSECTION; MEDLINE; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PSYCINFO; RACE DIFFERENCE; REVIEW; SURVIVAL TIME; SYSTEMATIC REVIEW;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MEDLINE; OVARIAN NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

EID: 68449093188     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9322-2     Document Type: Review

References (45)

1. A Jemal R Siegel E Ward 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010
2. CL Kosary 1994 FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina Semin Surg Oncol 10 31 46 10.1002/ssu.2980100107
3. GD Aletti SC Dowdy BS Gostout 2006 Aggressive surgical effort and improved survival in advanced-stage ovarian cancer Obstet Gynecol 107 77 85
4. DG Allen AP Heintz FW Touw 1995 A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary Eur J Gynaecol Oncol 16 349 356
5. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 1248 1259 10.1200/JCO.20.5. 1248 (Pubitemid 34177431)
6. DS Chi JB Liao LF Leon 2001 Identification of prognostic factors in advanced epithelial ovarian carcinoma Gynecol Oncol 82 532 537 10.1006/gyno.2001.6328 (Pubitemid 32826455)
7. SM Eisenkop RL Friedman HJ Wang 1998 Complete cytoreductive surgery is feasible and maximizes survival in patients Gynecol Oncol 69 103 108 10.1006/gyno.1998.4955 (Pubitemid 28246994)
8. WJ Hoskins WP McGuire MF Brady 1994 The effect of diameter of largest residual disease on survival after primary Am J Obstet Gynecol 170 974 979
9. T Le GV Krepart RJ Lotocki MS Heywood 1997 Does debulking surgery improve survival in biologically aggressive ovarian Gynecol Oncol 67 208 214 10.1006/gyno.1997.4839 (Pubitemid 27500422)
10. BA Goff BJ Matthews EH Larson 2007 Predictors of comprehensive surgical treatment in patients with ovarian cancer Cancer 109 2031 2042 10.1002/cncr.22604 (Pubitemid 46744198)
11. BA Goff BJ Matthews M Wynn HG Muntz DM Lishner LM Baldwin 2006 Ovarian cancer: patterns of surgical care across the United States Gynecol Oncol 103 383 390 10.1016/j.ygyno.2006.08.010 (Pubitemid 44602199)
12. JS Barnholtz-Sloan MA Tainsky J Abrams 2002 Ethnic differences in survival among women with ovarian carcinoma Cancer 94 1886 1893 10.1002/cncr.10415
13. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975-2005
14. V McGuire L Herrinton AS Whittemore 2002 Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization Epidemiology 13 231 234 10.1097/00001648-200203000-00021 (Pubitemid 34160501)
15. JK Chan M Zhang JM Hu JY Shin K Osann DS Kapp 2008 Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States J Surg Oncol 97 103 107 10.1002/jso.20932 (Pubitemid 351169035)
16. GP Parham ML Hicks 2005 Racial disparities affecting the reproductive health of African-American women Med Clin North Am 89 935 943 941
17. JS Barnholtz-Sloan AG Schwartz F Qureshi S Jacques J Malone AR Munkarah 2003 Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades Am J Obstet Gynecol 189 1120 1127 10.1067/S0002-9378(03) 00579-9 (Pubitemid 37373908)
18. LC Harlan LX Clegg EL Trimble 2003 Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J Clin Oncol 21 3488 3494 10.1200/JCO.2003.01.061 (Pubitemid 46594082)
19. X Du C Sun M Milam D Bodurka S Fang 2007 Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer Int J Gynecol Cancer 18 4 660 669
20. G Parham JL Phillips ML Hicks 1997 The national cancer data base report on malignant epithelial ovarian carcinoma in African-American women Cancer 80 816 826 10.1002/(SICI)1097-0142(19970815)80:4<816::AID-CNCR21>3.0.CO;2-V (Pubitemid 27339838)
21. RD Cress CD O'Malley GS Leiserowitz SL Campleman 2003 Patterns of chemotherapy use for women with ovarian cancer: a population-based study J Clin Oncol 21 1530 1535 10.1200/JCO.2003.08.065 (Pubitemid 46594106)
22. JP Higgins SG Thompson 2002 Quantifying heterogeneity in a meta-analysis Stat Med 21 1539 1558 10.1002/sim.1186 (Pubitemid 34746062)
23. PP Glasziou SL Sanders 2002 Investigating causes of heterogeneity in systematic reviews Stat Med 21 1503 1511 10.1002/sim.1183 (Pubitemid 34746059)
24. DS Alberts S Dahlberg SJ Green 1993 Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer Cancer 71 618 627
25. HE Averette MF Janicek HR Menck 1995 The national cancer data base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society Cancer 76 1096 1103 10.1002/1097-0142(19950915)76: 6<1096::AID-CNCR28207606263.0.CO;2-4
26. JK Chan R Urban MK Cheung 2006 Ovarian cancer in younger vs older women: a population-based analysis Br J Cancer 95 1314 1320 10.1038/sj.bjc.6603457 (Pubitemid 44760079)
27. JK Chan EG Munro MK Cheung 2007 Association of lymphadenectomy and survival in stage I ovarian cancer patients Obstet Gynecol 109 12 19
28. JK Chan R Urban JM Hu 2007 The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients Br J Cancer 96 1817 1822 10.1038/sj.bjc.6603803 (Pubitemid 46912018)
29. V McGuire CA Jesser AS Whittemore 2002 Survival among U.S. women with invasive epithelial ovarian cancer Gynecol Oncol 84 399 403 10.1006/gyno.2001. 6536 (Pubitemid 34211865)
30. MA Morgan K Behbakht I Benjamin M Berlin SA King SC Rubin 1996 Racial differences in survival from gynecologic cancer Obstet Gynecol 88 914 918 10.1016/S0029-7844(96)00342-0 (Pubitemid 26391489)
31. KA Munoz LC Harlan EL Trimble 1997 Patterns of care for women with ovarian cancer in the United States J Clin Oncol 15 3408 3415
32. CD O'Malley RD Cress SL Campleman GS Leiserowitz 2003 Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study Gynecol Oncol 91 608 615 10.1016/j.ygyno.2003.08.010 (Pubitemid 38388159)
33. D Polsky KA Armstrong TC Randall 2006 Variation in chemotherapy utilization in ovarian cancer: the relative contribution of geography Health Serv Res 41 2201 2218 10.1111/j.1475-6773.2006.00596.x (Pubitemid 44760150)
34. JP Smith TG Day Jr 1979 Review of ovarian cancer at the University of Texas Systems Cancer Center. M.D. Anderson Hospital and Tumor Institute Am J Obstet Gynecol 135 984 993
35. V Sundararajan D Hershman VR Grann JS Jacobson AI Neugut 2002 Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study J Clin Oncol 20 173 178 10.1200/JCO.20.1.173 (Pubitemid 34032609)
36. WE Winter III GL Maxwell C Tian 2007 Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 3621 3627 10.1200/JCO.2006.10.2517 (Pubitemid 47372600)
37. J Young LG Ries ES Pollack 1984 Cancer patient survival among ethnic groups in the United States J Natl Cancer Inst 73 341 352
38. E Ferreira AM Carceller C Agogue 2007 Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates Pediatrics 119 52 59 10.1542/peds.2006-2133 (Pubitemid 46397842)
39. G Omura JA Blessing CE Ehrlich 1986 A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin Cancer 57 1725 1730 10.1002/1097-0142(19860501)57:9<1725::AID-CNCR2820570903>3.0.CO;2-J
40. GA Omura BN Bundy JS Berek S Curry G Delgado R Mortel 1989 Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin J Clin Oncol 7 457 465
41. CT Griffiths 1975 Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr 42 101 104
42. Farley JH, Tian C, Rose GS, Brown CL, Risinger JI, Maxwell GL (2008) Ethnicity and clinical outcomes for advanced epithelial ovarian cancer patients treated by standard cisplatin/paclitaxel chemotherapy: a combined analysis of gynecologic oncology group clinical trials. J clin Oncol 26: abstr 5537
43. Adler N, Stewart J, Cohen S et al. (2008) Reaching for a Healthier Life: facts on Socioeconomic Status and Health in the US. John D. and Catherine T MacArthur Foundation
44. Sugiyama VE, Shin JY, Kapp DS et al. (2008) The effect of socioeconomic status on the survival of ovarian cancer patients. J Clin Oncol 26: p. abstr 5557
45. N Krieger C Quesenberry Jr T Peng 1999 Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States) Cancer Causes Control 10 525 537 10.1023/A:1008950210967